G&S Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,831
Closed -$2.17M 126
2023
Q3
$2.17M Buy
16,831
+3,030
+22% +$402K 1.1% 37
2023
Q2
$1.83M Sell
13,801
-24
-0.2% -$3.16K 0.88% 45
2023
Q1
$1.79M Buy
13,825
+77
+0.6% +$10.1K 0.79% 43
2022
Q4
$1.87M Sell
13,748
-284
-2% -$37.6K 0.83% 39
2022
Q3
$1.7M Buy
14,032
+150
+1% +$19.3K 0.9% 32
2022
Q2
$1.78M Buy
+13,882
New +$1.82M 1.05% 30

Other funds holding XLV

G&S Capital's XLV Position: Q4 2023 in Review

G&S Capital sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2023, closing a stake of 16,831 shares — an estimated $2.17M sold.

G&S Capital first reported a position in XLV in Q2 2022 and held it in 6 quarters. The position peaked at $2.17M in Q3 2023. 1,642 funds tracked by Wall St. Rank hold XLV as of Q4 2023.

  • G&S Capital reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2023 after selling out during the quarter.
  • G&S Capital sold 16,831 State Street Health Care Select Sector SPDR ETF shares in Q4 2023, an estimated $2.17M.
  • G&S Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2022 and held it in 6 quarters.
  • G&S Capital's State Street Health Care Select Sector SPDR ETF position peaked at $2.17M in Q3 2023.
  • 1,642 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2023.

Based on G&S Capital's 13F filing for Q4 2023, filed 29 Jan 2024.